|
Q4 FY2025
As of Sep 30, 2025
|
Q4 FY2024
As of Sep 30, 2024
|
Q4 FY2023
As of Sep 30, 2023
|
Q4 FY2022
As of Sep 30, 2022
|
Q4 FY2021
As of Sep 30, 2021
|
Q4 FY2020
As of Sep 30, 2020
|
Q4 FY2019
As of Sep 30, 2019
|
Q4 FY2018
As of Sep 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||
| Short-term deposit | ||||||||
| Cash and restricted cash | ||||||||
| Short-term deposit | ||||||||
| Short-term investments | ||||||||
| Notes receivable | ||||||||
| Accounts receivable, net | ||||||||
| Advances to suppliers, net | ||||||||
| Other receivable | ||||||||
| Note receivable, current portion | ||||||||
| Inventories, net | ||||||||
| Other current assets, net | ||||||||
| Due from a related party | ||||||||
| Total current assets | ||||||||
| Biological assets, net | ||||||||
| Non-current assets | ||||||||
| Note receivable | ||||||||
| Long-term investments, net | ||||||||
| Biological assets, net | ||||||||
| Right-of-use assets, net | ||||||||
| Deferred tax assets | ||||||||
| Security deposits | ||||||||
| Property and equipment, net | ||||||||
| Intangible assets, net | ||||||||
| Other non-current assets | ||||||||
| Total non-current assets | ||||||||
| Total assets | ||||||||
| Current liabilities | ||||||||
| Short-term loans | ||||||||
| Advances from customers | ||||||||
| Total long-term loans - current portion | ||||||||
| Derivative liability | ||||||||
| Note payable | ||||||||
| Convertible promissory notes | ||||||||
| Promissory notes | ||||||||
| Accounts payable | ||||||||
| Due to related parties | ||||||||
| Operating lease liabilities - current | ||||||||
| Other current liabilities | ||||||||
| Total current liabilities | ||||||||
| Non-current liabilities | ||||||||
| Total long-term loans - non-current portion | ||||||||
| Operating lease liabilities - non-current | ||||||||
| Other non-current liabilities | ||||||||
| Total non-current liabilities | ||||||||
| Total liabilities | ||||||||
| Shareholders' equity | ||||||||
| Ordinary shares, $2.40 par value, 5 billion shares authorized, 5,481,874 and 889,906 shares issued and outstanding as of September 30, 2025 and 2024, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Statutory reserve | ||||||||
| (Accumulated deficit) Retained earnings | ||||||||
| Accumulated other comprehensive (loss) income | ||||||||
| Accumulated other comprehensive loss | ||||||||
| Total Farmmi, Inc.'s shareholders' equity | ||||||||
| Noncontrolling interest | ||||||||
| Total shareholders' equity | ||||||||
| Total liabilities and shareholders' equity | ||||||||
Loading...
